Adcendo

News

Beeline raises $300m for BMS drugs, and other biofinancings

Beeline Medicines, Oricell, Terremoto, Harbinger, Neomorph, Adcendo, and STORM all closed impressive financing rounds in the last week.

News

Adcendo raises $135m for cancer ADCs, and other financings

Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma

News

Adcendo licenses Multitude anti-TF ADC in $1bn+ deal

Danish biotech Adcendo has accelerated its progression to a clinical-stage biotech by licensing an antibody-drug conjugate (ADC) from China's Multitude Therapeutics with potential in variou

Beeline raises $300m for BMS drugs, and other biofinancings

Adcendo raises $135m for cancer ADCs, and other financings

Adcendo licenses Multitude anti-TF ADC in $1bn+ deal

ESC26: Isomab safety evidence on blood vessel growth for CAD

Discover a new era of healthcare panel engagement: Grounded ...

Editor's Picks